Subscribe now

Health

Why gene editors want to treat fetuses when they are still in the womb

Gene editing in the womb could be more effective than the same treatment after birth, as it is easier to deliver the necessary genetic machinery to fetal cells

By Michael Le Page

25 November 2024

Gene editing could be more effective before birth

Leigh Prather/Alamy

Doing CRISPR gene editing while fetuses are in the womb could make it easier to treat inherited conditions, especially those affecting tissues such as the heart or muscles.

Kiran Musunuru at the University of Pennsylvania and his colleagues have tested gene editing in monkeys, and found that it was far more effective when given before birth. “What we found was astounding,” he says. “It opens up the opportunity to treat diseases that have been very hard to treat after birth.”

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox! We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers